Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 14, 2025 • 3:00 PM ET

Date/Time Source News Release
06/10/2025 08:56 AM EDT GlobeNewswire Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension
05/15/2025 08:00 AM EDT GlobeNewswire Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Business Update
05/12/2025 08:00 AM EDT GlobeNewswire Galectin Therapeutics Presented NAVIGATE Trial Results at the European Association for the Study of the Liver (EASL) 2025 Congress
04/15/2025 08:00 AM EDT GlobeNewswire Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2025 Congress
03/31/2025 08:00 AM EDT GlobeNewswire Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update
02/18/2025 08:00 AM EST GlobeNewswire Galectin Therapeutics Reports Significant Reduction in New Varices with Belapectin in U.S. Patient Population from the NAVIGATE Trial
01/10/2025 08:00 AM EST GlobeNewswire Galectin Therapeutics to Present at the 2025 MASH-TAG Conference
12/20/2024 08:00 AM EST GlobeNewswire Galectin Therapeutics Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH
11/18/2024 08:00 AM EST GlobeNewswire Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
11/14/2024 08:00 AM EST GlobeNewswire Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update
Page

Additional News

As of June 14, 2025 • 3:00 PM ET

Date/Time Source News Release
05/16/2025 05:30 AM EDT US Earnings Reports Expected earnings - Galectin Therapeutics Inc.
05/15/2025 08:20 AM EDT SeekingAlpha Galectin Therapeutics GAAP EPS of -$0.15
04/07/2025 09:40 AM EDT Zacks Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
04/01/2025 05:30 AM EDT US Earnings Reports Expected earnings - Galectin Therapeutics Inc.
03/31/2025 08:10 AM EDT SeekingAlpha Galectin Therapeutics GAAP EPS of -$0.76
12/21/2024 11:00 AM EST SeekingAlpha Investors Looking To Durable Goods, New-Home Sales Data As Earnings Season Winds Down
12/20/2024 03:00 PM EST SeekingAlpha Catalyst Watch: Labor pains for Amazon & Starbucks, Nasdaq call-up for MicroStrategy and Pony AI ratings
12/20/2024 08:36 AM EST SeekingAlpha Galectin drops as trial for lead asset fails in MASH
12/09/2024 09:35 AM EST Zacks Here's Why Galectin Therapeutics (GALT) is Poised for a Turnaround After Losing -31.83% in 4 Weeks
11/30/2024 10:00 AM EST SeekingAlpha Salesforce, Marvell Technology, And Kroger Report As Earnings Season Slowing To A Crawl
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.